The Roche drug, Ocrevus, secured FDA approval for two forms of multiple sclerosis.
Look ahead, Jim Cramer says. This might be a good time to buy industrials, financials, FANG, and tech opportunities.
Jim Cramer is bullish on Sirius XM Radio, Kratos Defense and Security, and Marriott International.
A firestorm in Washington has created a fire sale for shares of this undervalued stock.